Category: News Well
Content tagged to appear in the middle column of the home page
Medtech titan Medtronic says that it's not involved with research on an orgasm-inducing neurostimulation system, despite reports to the contrary.
Medical device industry giant Medtronic (NYSE:MDT) told MassDevice.com today that despite reports of the company's participation in upcoming studies, Medtronic is not involved with research on an implantable neurostimulator designed for treatment of sexual dysfunction.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
Here's a look at some of the top funding stories for medical device companies this week.
EarLens said it raised some $36 million in an equity round for the hearing aid technology it's developing that uses infrared rather than sound waves.
Ascension Health Ventures
, Benvenue Medical Inc.
, Cheetah Medical
, Fletcher Spaght Ventures
, MVM Life Science Partners
, NxThera Inc.
, Robert Bosch Venture Capital
, Springfield Investments
Analogic is on track with layoffs and facilities closures announced last year, but ALOG shares dive after the company reports disappointing earnings for its 2nd quarter and projects flat progress for the year ahead.
New York's AngioDynamics lands FDA clearance for a new BioFlo product and takes charge of distribution partner Medcomp's Celerity tip locater after an FDA loss.
Edwards Lifesciences says the 1st 3 patients worldwide were implanted with its Fortis transcatheter mitral valve implant.
Edwards Lifesciences (NYSE:EW) said a surgical team at London's St. Thomas' Hospital implanted the 1st 3 patients with its Fortis transcatheter mitral valve implant.